Financial Services • NYSE
According to Zyberno, RENASANT CORP (RNST) is not a buy — WEAK BUSINESS (42/100) with a negative Margin of Safety of -63.4% and a Brina Gap of -1.0% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, RENASANT CORP (RNST) trades at $41.09 against an estimated intrinsic value per share of $25.15 — a -63.4% Margin of Safety based on Owner Earnings of $243.90M TTM, projected at -5.0% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -1.0% weakens the case: based on the company's ROIC (7.6%) and reinvestment rate (3.5%), the business can fundamentally grow at 0.3% — but the current enterprise value implies the market expects 1.2%. This places RNST in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of -13.9% annually.
Over the trailing twelve months, RNST generated $243.90M in Owner Earnings. Capital was deployed as follows: $75.81M returned via share buybacks, $87.02M paid as dividends, $35.23M invested in capital expenditures. Reinvestment rate: 3.5%. Owner Earnings have declined at 5.0% annually over the trailing five years using log-linear regression.